Robert Eugene Watson
CIK 1511858 · President & CEO · last filed 2025-07-29
Robert Eugene Watson is a President & CEO who has filed 30 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing shows the insider bought $20.0K of CVM on Jul 29, 2025. Across all open-market trades the lifetime net is +$344.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.0K
3
30
$344.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVM | Director | 3,733 | $1.08 | $4.0K | $77.2K | 13 | 2025-07-29 |
| CEL SCI CORP (CVM.WS) Delisted | Director | — | — | — | $0 | 2 | 2018-05-03 |
| STREAMLINE HEALTH SOLUTIONS INC. (STRM) Delisted | President & CEO | 272,542 | $5.33 | $1.45M | $267.6K | 15 | 2015-01-22 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-29 | CVM | Buy (P) | +2,919 | $20.0K | EDGAR |
| 2025-07-29 | CVM | Grant (A) | — | $0 | EDGAR |
| 2024-05-10 | CVM | Buy (P) | +20,000 | $27.8K | EDGAR |
| 2024-04-23 | CVM | Grant (A) | — | $0 | EDGAR |
| 2023-08-10 | CVM | Grant (A) | — | $0 | EDGAR |
| 2022-06-14 | CVM | Grant (A) | — | $0 | EDGAR |
| 2021-07-07 | CVM | Buy (P) | +1,250 | $10.0K | EDGAR |
| 2021-05-17 | CVM | Grant (A) | — | $0 | EDGAR |
| 2020-11-18 | CVM | Buy (P) | +800 | $9.4K | EDGAR |
| 2020-04-20 | CVM | Grant (A) | — | $0 | EDGAR |